ATRA

ATARA BIOTHERAPEUTICS INC

ATRA·046513206·US·Common Stock·Healthcare - Biotechnology-Activist

ATRA (ATARA BIOTHERAPEUTICS INC) is held by 24 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($3.3M), MACKENZIE FINANCIAL CORP ($1.5M), VANGUARD CAPITAL MANAGEMENT LLC ($1M). Net institutional sentiment: Mixed.

24
Holders
Avg rating(6 Elite)
$8.5M
Total Value
54% (34)
Fund Consensus
14 buying - 12 selling
ATRASmart Money Verdict
View all
Held by 24 funds
6 elite
Who's Trading
ActivistRERedmile Group, LLC9.9%May 14, 2026
ActivistADAdage Capital Management, L.P.8.6%May 13, 2026
ActivistPIPanacea Innovation Limited16.1%May 11, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.6.2%May 8, 2026
InsiderPLPanacea Innovation LtdSell $3.2MMay 7, 2026
ActivistECEcoR1 Capital, LLC17.4%May 7, 2026
InsiderNANguyen AnhCoSell $1KMar 2, 2026
InsiderNANguyen AnhCoSell $294.64Mar 2, 2026
InsiderNANguyen AnhCoSell $7KMar 2, 2026
InsiderNANguyen AnhCoSell $7KMar 2, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
700,000$3.3M0.0%+80.07%
37
Increased
313,620(+434.6%)$1.5M0.0%+47.80%
41
New
217,862$1M0.0%+80.07%
38
Increased
194,264(+961.8%)$918,8690.0%+48.02%
40
Increased
79,022(+17.8%)$373,7730.0%-14.79%
19
Increased
66,146(+6.0%)$313,0450.0%-96.47%
17
Increased
50,070(+3484.1%)$236,8310.0%+75.58%
25
New
47,689$225,5690.0%+80.07%
32
Increased
33,870(+142.1%)$160,2060.0%+9.84%
25
New
33,621$159,0270.0%+80.07%
34
Unchanged
26,453$125,1230.0%-16.73%
0
Decreased
16,238(-5.3%)$76,8060.0%-26.51%
0
Unchanged
12,340$58,3680.0%-29.11%
0
Decreased
9,169(-42.7%)$43,3700.0%-20.01%
0
Increased
4,319(+408.1%)$20,0000.0%+67.38%
21
New
1,456$6,8870.0%+80.07%
25
Unchanged
703$3,2270.0%+15.11%
0
Unchanged
251$1,1870.0%-33.98%
0
Unchanged
216$9330.0%-26.51%
0
Unchanged
175$8270.0%-97.99%
0

Showing 1-20 of 34

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used